Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-20-064437

Chief Financial Officer sold 36,923 shares at $1.32 ($48,628)

  • Chief Financial Officer acquired 36,923 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-16 Exercise or conversion : show line 1 in the form +36,923 $0.17 $6,118 386,533 D
2020-12-16 Sale : show line 2 in the form −36,923 $1.32 $48,628 349,610 D
Open-market sales · 36,923 sh · avg $1.32 · $48,628

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2020-12-16 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −36,923 $0.17 $6,118 $0.17 2024-01-28 36,923 36,923 D
Loading xslF345X03/doc4.xml…